SOPHiA GENETICS (SOPH) Return on Equity (2021 - 2025)

SOPHiA GENETICS has disclosed Return on Equity across 5 years of filings, most recently posting 0.01% for Q4 2025.

• Return on Equity for Q4 2025 came in at 0.01%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
• Return on Equity came in at 0.01% for Q4 2025 at SOPHiA GENETICS, down from 0.07% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 7.04% in Q1 2021 to a low of 0.09% in Q2 2024.
• The 5-year median for Return on Equity is 0.02% (2023), against an average of 0.6%.
• Peak annual rise in Return on Equity reached 7 bps in 2022, while the deepest fall reached 703 bps in 2022.
• SOPHiA GENETICS's Return on Equity stood at 0.01% in 2021, then retreated by 6 bps to 0.01% in 2022, then climbed by 7 bps to 0.01% in 2023, then retreated by 6 bps to 0.01% in 2024, then rose by 0 bps to 0.01% in 2025.
• The last three Return on Equity figures came in at 0.01% (Q4 2025), 0.07% (Q3 2025), and 0.06% (Q2 2025), per Business Quant data.